Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
Amedisys, Inc. (NASDAQ: AMED) will report its fourth quarter and full year results for 2021 on February 23, 2022, after market close.
Rhea-AI Summary
Amedisys, Inc. (NASDAQ: AMED) will report its fourth quarter and full year results for 2021 on February 23, 2022, after market close. An investor conference call is scheduled for February 24, 2022, at 11:00 a.m. ET. Participants can join by dialing (877) 524-8416 or (412) 902-1028. A replay will be available until March 24, 2022. A live webcast will also be accessible on the Company's Investor Relations website. Amedisys focuses on delivering personalized home health, hospice, personal care, and higher acuity care services nationwide.
Positive
- Scheduled release of fourth quarter and full year results on February 23, 2022, which may provide insights into future performance.
- Investor conference call on February 24, 2022, allowing direct communication regarding the company’s financial health and strategy.
Negative
- None.
Details
News Market Reaction – AMED
The recorded move for AMED in the trading session of this news was +4.79%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for the fourth quarter and year ended December 31, 2021, after the market closes on February 23, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on February 24, 2022.
To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (toll-free) or (412) 902-1028 (toll). A replay of the call will be available through March 24, 2022, by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and entering access ID 13726704.
A live webcast of the call will be accessible through the Company website on the Investor Relations section at http://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and higher acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,900 hospitals and 78,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, La. with an executive office in Nashville, Tenn., Amedisys is a publicly held company. With ~21,000 employees, in 528 care centers in 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 418,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
| Contact: | |
| Nick Muscato | Kendra Kimmons |
| Amedisys, Inc. | Amedisys, Inc. |
| Investor Relations | Media Relations |
| 615.928.5452 | 225.299.3720 |
| nick.muscato@amedisys.com | Kendra.kimmons@amedisys.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.